← Open Payments lookup

TINA CUBETA: Open Payments

NPI 1184907743 · WILMINGTON, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,084 in 38 payments from 13 companies in 2025. Trend: 2023 $1,076 · 2024 $981 · 2025 $1,084

Food & beverage: $1,084
CompanyPaymentsAmount
Axsome Therapeutics, Inc.9$317
E.R. Squibb & Sons, L.L.C.2$150
Otsuka America Pharmaceutical, Inc.3$122
Lundbeck LLC5$106
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$84
Vanda Pharmaceuticals Inc.4$76
Takeda Pharmaceuticals U.S.A., Inc.3$74
Neurocrine BioSciences, Inc.2$44
Corium, LLC2$43
ABBVIE INC.1$17

Products named: Auvelity, REXULTI, COBENFY, CAPLYTA, TRINTELLIX, FANAPT, INGREZZA, Azstarys.

Industry payments across DE — which companies pay providers there.